Blog
RSS FeedPosted by Michael Wonder on 30 May 2023
‘A victim of its own success’: inside the great Ozempic shortage
26 May 2023 - The drug is approved in Australia to treat type 2 diabetes but people have flocked to it ...
Posted by Michael Wonder on 30 May 2023
ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older
30 May 2023 - ATAGI has made recommendations on the use of bivalent COVID-19 vaccines as a primary course. ...
Posted by Michael Wonder on 29 May 2023
MSAC publishes agenda for August PASC meeting
29 May 2023 - The MSAC Secretariat has published a list of applications scheduled to be considered by the PICO ...
Posted by Michael Wonder on 25 May 2023
Australians battling with prostate cancer to benefit from new PBS listing
25 May 2023 - Australians battling prostate cancer that has spread past the prostate will soon benefit from subsidised medicine ...
Posted by Michael Wonder on 24 May 2023
PBAC Public Summary Document - May 2023
24 May 2023 - The Public Summary Document of the PBAC's consideration of the interim report of the post-market review of ...
Posted by Michael Wonder on 24 May 2023
New life changing treatment for dwarfism added to PBS
24 May 2023 - Children born with the most common form of dwarfism will have access to a new life ...
Posted by Michael Wonder on 24 May 2023
Revolutionising MS treatment: new form of Tysabri recommended for PBS listing
24 May 2023 - The PBAC has recommended the listing of natalizumab (Tysabri) pre-filled syringe for subcutaneous injection on the PBS. ...
Posted by Michael Wonder on 21 May 2023
Is the quality of evidence in health technology assessment deteriorating over time? A case study on cancer drugs in Australia.
18 May 2023 - This study aimed to assess whether there have been changes in the quality of clinical evidence ...
Posted by Michael Wonder on 16 May 2023
RACGP welcomes asthma puffer decision saving Aussie families time and money
15 May 2023 - The Royal Australian College of GPs (RACGP) has welcomed the PBAC's decision to remove limitations requiring ...
Posted by Michael Wonder on 14 May 2023
Pharmacy Guild rebuked over scare campaign on medicine shortages
15 May 2023 - A long-time chair of the government’s independent pharmaceutical advisory body has rebuked the powerful pharmacy lobby ...
Posted by Michael Wonder on 13 May 2023
PBAC dismisses Pharmacy Guild concerns on 60 day dispensing
12 May 2023 - The chair of the PBAC has dismissed concerns that 60 day dispensing will cause medicine shortages, ...
Posted by Michael Wonder on 12 May 2023
Public Consultation: draft 2023-24 Cost Recovery Implementation Statement (CRIS) for listing medicines on the PBS and designated vaccines on the NIP
12 May 2023 - Consultation on the draft 2023-24 Cost Recovery Implementation Statement (CRIS) for listing medicines on the Pharmaceutical ...
Posted by Michael Wonder on 12 May 2023
PBAC backs ongoing access to low-dose asthma puffer for Aussie kids
12 May 2023 - The independent, expert group advising the Australian Government on PBS medications has reviewed its recommendation to put ...
Posted by Michael Wonder on 12 May 2023
Outcome in relation to fluticasone propionate – May 2023 PBAC intracycle meeting
12 May 2023 - The outcome for fluticasone propionate from the May 2023 PBAC meeting is now available. ...
Posted by Michael Wonder on 11 May 2023
Federal budget 2023: doctors praise $1.5 billion cash injection
10 May 2023 - The long-term trend of inadequate indexation of medical rebates is set to end after the federal ...